Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology ; volume:13 ; number:1 ; day:4 ; month:1 ; year:2024 ; pages:1-24 ; date:12.2024
Translational neurodegeneration ; 13, Heft 1 (4.1.2024), 1-24, 12.2024
- Creator
-
Gebril, Hoda M.
Aryasomayajula, Aravind
Lima, Mariana Reis Nogueira de
Uhrich, Kathryn E.
Moghe, Prabhas V.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-023-00393-7
- URN
-
urn:nbn:de:101:1-2024031813171070226957
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gebril, Hoda M.
- Aryasomayajula, Aravind
- Lima, Mariana Reis Nogueira de
- Uhrich, Kathryn E.
- Moghe, Prabhas V.
- SpringerLink (Online service)
Other Objects (12)
Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Microglial Activation in Alzheimer’s Disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer’s disease pathology
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer’s disease mice by controlling astrocyte activation
Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Microglial Activation in Alzheimer’s Disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer’s disease pathology
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer’s disease mice by controlling astrocyte activation
Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Microglial Activation in Alzheimer’s Disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer’s disease pathology
Alzheimer’s disease: natural products as inhibitors of neuroinflammation